Preveceutical Med Inc New
(PRVCF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 75 | 3 | 4 | 43 | 0 |
| Receivables | 14 | 11 | 26 | 20 | 19 |
| TOTAL | $214 | $145 | $67 | $85 | $249 |
| Non-Current Assets | |||||
| PPE Net | 3 | 3 | 1 | 2 | 2 |
| Intangibles | 115 | 114 | 112 | 78 | 83 |
| TOTAL | $117 | $117 | $114 | $79 | $85 |
| Total Assets | $331 | $262 | $181 | $165 | $333 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,289 | 3,244 | 3,158 | 3,210 | 3,106 |
| Accounts payable and accrued liabilities | 2,361 | 2,146 | 2,006 | 1,753 | 1,787 |
| TOTAL | $5,651 | $5,390 | $5,163 | $4,962 | $4,893 |
| Non-Current Liabilities | |||||
| Long Term Debt | 47 | 47 | 44 | 46 | 46 |
| TOTAL | $47 | $47 | $44 | $46 | $46 |
| Total Liabilities | $5,698 | $5,436 | $5,208 | $5,008 | $4,938 |
| Shareholders' Equity | |||||
| Common Shares | 15,130 | 14,708 | 13,700 | 14,300 | 14,352 |
| Retained earnings | -23,476 | -22,802 | -21,118 | -21,573 | -21,491 |
| Other shareholders' equity | 2,979 | 2,920 | 2,390 | 2,430 | 2,534 |
| TOTAL | $-5,367 | $-5,175 | $-5,027 | $-4,844 | $-4,605 |
| Total Liabilities And Equity | $331 | $262 | $181 | $165 | $333 |